Maureen Watt

Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement

Maureen Watt, Stuart Mealing, James Eaton et al. · Heart · 2011 · 125 citations · Full text

Antibiotic research and development: business as usual?

Stephan Harbarth, Ursula Theuretzbacher, Judith Hackett et al. · Journal of Antimicrobial Chemotherapy · 2015 · 83 citations · Full text

A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany

Maureen Watt, Charles McCrea, Sukhvinder Johal et al. · Infection · 2016 · 44 citations · Full text

Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in Spain

Carlos Rubio-Terrés, Javier Cobo Reinoso, Santiago Grau Cerrato et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2015 · 38 citations

Antimicrobial Stewardship, Antibiotics, Health Economics +10

The impact of Clostridium difficile infection on resource use and costs in hospitals in Spain and Italy: a matched cohort study

Ángel Asensio, Stefano Di Bella, Andrea Lo Vecchio et al. · International Journal of Infectious Diseases · 2015 · 31 citations · Full text